Biopharmaceutical sponsors are under intense pressure to reduce the time required for drug development. As a result, these sponsors are continually searching for new approaches to reduce lead-time and costs without affecting the quality of the clinical trial deliverables and execution. Read this case study to learn how the Clinical Supply Optimization Enhanced Service model was able to simplify the process and saved an average of 30% of the sponsor’s time.